May 2012 – Tim Moran was an invited panelist at the National Institutes of Health Pediatric Device Workshop: Designing a Roadmap for Pediatric Device Development sponsored by Eunice Kennedy Shriver National Institute for Child Health and Human Development, the Food and Drug Administration, the Agency for Health Care Quality and Research and the Health Resources and Services Administration.  This workshop aimed to outline pathways for new inventions targeted for children and adapting adult devices for pediatric use.

September 2011 – Tim Moran discussed his perspectives on identifying an unmet need in medicine and personalizing it to a specific patient population as a panelist at the Cleveland Clinic’s Personalized Healthcare Summit on September 20, 2011.  The Summit is a 2-day conference dedicated to hosting an intellectual forum to explore the disruptive innovation of Personalized Healthcare delivery, share experiences, develop collaborations, and create a roadmap to enable the practice of personalized healthcare.

April 2011Tim Moran was an invited speaker at the Design of Medical Devices (DMD) Conference at the University of Minnesota where he discussed the challenges for developing and commercializing pediatric medical devices.  The DMD Conference provides a national forum to bring together world-class medical device designers, researchers, manufacturers, and the public sector to share perspectives and innovations in medical device design.  

April 2011 – Tim Moran was an invited speaker at the Stanford Medical Innovation Conference where he discussed unique approaches for funding and launching companies that focus on small population segments.  The Stanford Medical Innovation Conference aims to provide a unique forum for engineers, doctors, business professionals, and students to come together and discuss a pioneering topic of biomedical technology development. The event consists of a series of talks, demonstrations, and mixer sessions to facilitate communication and collaboration between premier universities and industry R&D centers.

September 2010 – In an interview with MedCity News Tim Moran discusses the mission of PediaWorks and why he hopes it goes out of business.  Read the full article by clicking here


July 2010PediaWorks and Medikit Co., Ltd. announced the formation of PediaVascular, Inc., a joint venture to help alleviate the severe shortage of medical devices for use in pediatric patients.  PediaVascular will be the first and only company to develop catheters just for children. 

“It’s critical that our nation’s children have access to cutting-edge medical treatment, which is why this new initiative between PediaWorks and Medikit is so important,” said U.S. Senator Sherrod Brown. “Too often, medical devices are not made with children in mind. Because of the unique set of circumstances that discourage innovation in pediatric medical research and development, thinking outside the box becomes a necessity. This important new venture does just that.  This initiative will help ensure that our children have the right medical devices designed for their growing bodies and further cement Cleveland as a hub for medical research and development.”

Medikit is contributing $500,000 cash as seed funding, its experienced team of R&D engineers and rapid prototyping facilities.  PediaWorks is providing executive management and access to its broad network of pediatric clinical advisors and research partners.  Tim Moran, founder of PediaWorks, will serve as PediaVascular‘s president and CEO.  The company will be headquartered in Cleveland, Ohio.

“We are grateful Medikit has the compassion to undertake this venture and feel it will be an ideal model to procure pediatric devices quickly and efficiently,” said Tim Moran.  Nobufumi Kurita, CEO of Medikit stated, “Medikit is very pleased to join PediaWorks in such a worthwhile endeavor.  By leveraging our advanced design and development capabilities in Japan we hope to improve the health of children worldwide.”

About Medikit: Founded in 1973, Medikit (JASDAQ: 7749) is a world-leading manufacturer of interventional cardiology, IV and hemodialysis catheters.  With headquarters in Tokyo and several locations throughout Japan and Vietnam, it distributes products across Asia, Europe and the Americas.

Click here for PR Newswire release